We are live on ! Find out more
CTXRW

Citius Pharmaceuticals, Inc. Warrant
CTXRW

Delisted

CTXRW was delisted on the 8th of August, 2022.

Back to rankings

2 hedge funds and large institutions have $14K invested in Citius Pharmaceuticals, Inc. Warrant in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$15.5K
2
UBS Group
UBS Group
Switzerland
+$2.05K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$12K +$15.5K +23,900 New
UBS Group
2
UBS Group
Switzerland
$2K +$2.05K +3,165 New

CTXRW Hedge Fund Activity: Q3 2017 in Review

2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals, Inc. Warrant (CTXRW) for Q3 2017, worth a combined $14K.

Buyers outnumbered sellers: 2 funds opened new CTXRW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $15.5K.

  • 2 institutional investors held Citius Pharmaceuticals, Inc. Warrant (CTXRW) as of Q3 2017, up from 0 in Q2 2017.
  • Funds reported $14K of Citius Pharmaceuticals, Inc. Warrant stock for Q3 2017.
  • 2 funds opened new Citius Pharmaceuticals, Inc. Warrant positions in Q3 2017 and 0 closed out, a net change of +2 holders.
  • The largest Citius Pharmaceuticals, Inc. Warrant buyer in Q3 2017 was Virtu Financial, an estimated $15.5K added.

Based on aggregated 13F filings for Q3 2017.